Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cephalon

1987 FOUNDED
M&A STATUS
701-800 EMPLOYEES
M&A LATEST DEAL TYPE
$6.8B LATEST DEAL AMOUNT
Description

Developer of pharmaceuticals intended to treat diseases related to central nervous system, oncology and inflammatory diseases. The company's pharmaceutical products are used for the treatment of sleep disorders, pain, addiction and cancer, enabling patients to find quick remedies for their diseases.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Primary Office
  • 41 Moores Road
  • Frazer
  • Malvern, PA 19355
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cephalon’s full profile, request a free trial.

Cephalon Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 14-Oct-2011 $6.8B 00.00 Completed Generating Revenue
3. Merger/Acquisition 05-Apr-2011 00.00 00.00 Cancelled Generating Revenue
2. IPO 25-Apr-1991 Completed Startup
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cephalon Investments & Acquisitions (20)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0ü0 000 10-Jan-2012 000000000000000000 Clinics/Outpatient Services
00000 0 0000000000 01-Apr-2011 000000000000000000 00000 Pharmaceuticals
000000000 00000000 29-Mar-2011 000000000000000000 00000 Biotechnology
000000000 11-Feb-2011 0000 00000 Biotechnology
Alba Therapeutics (Larazotide Acetate Assets) 09-Feb-2011 Corporate Asset Purchase 0000 Biotechnology 00000 00000
To view this company’s complete investment and acquisition history, request access »

Cephalon Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000 05-Jan-2004 00000 00000 00 00.000 Completed
  • 5 buyers
To view this company’s complete exits history, request access »

Cephalon Subsidiaries (2)

Company Name Industry Location Founded
Fachklinik für Amputationsmedizin Osterhofen Clinics/Outpatient Services Osterhofen, Germany 1999
00000 Biotechnology Basel, Switzerland 0000
To view this company’s complete subsidiary history, request access »

Cephalon Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ben Franklin Technology Partners of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
New Leaf Venture Partners Venture Capital Minority 000 0000 000000 0
New Science Ventures Venture Capital Minority 000 0000 000000 0
Oak Investment Partners Venture Capital Minority 000 0000 000000 0
SR One Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »